C. Tropé
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment 23
- Obstetrics and Gynecology top 2%
- Endometrial and Cervical Cancer Treatments 13
- Cancer Research top 10%
-
- Cancer Treatment and Pharmacology 3
-
- Colorectal and Anal Carcinomas 3
- Intraperitoneal and Appendiceal Malignancies 3
-
- BRCA gene mutations in cancer 4
- Estrogen and related hormone effects 4
-
- Radiopharmaceutical Chemistry and Applications 2
C. Tropé
43 papers receiving 971 citations
Peers
Comparison fields: 5 of 73
- Reproductive Medicine 425
- Obstetrics and Gynecology 380
- Cancer Research 219
- Oncology 215
- Surgery 263
Countries citing papers authored by C. Tropé
This map shows the geographic impact of C. Tropé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Tropé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Tropé more than expected).
Fields of papers citing papers by C. Tropé
This network shows the impact of papers produced by C. Tropé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Tropé. The network helps show where C. Tropé may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C. Tropé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 18 | |
| 2 | High-resolution Image Analysis - A Better Method for Predicting Prognosis in Early Ovarian Cancer | 2000 | 2 |
| 3 | 2000 | 88 | |
| 4 | 2000 | 163 | |
| 5 | 2000 | 46 | |
| 6 | 1999 | 13 | |
| 7 | 1997 | 21 | |
| 8 | 1997 | 44 | |
| 9 | 1997 | 32 | |
| 10 | Randomized trial on adjuvant carboplatin versus no treatment in stage I high risk ovarian cancer by th Nordic Ovarian Cancer Study Group (NOCOVA) | 1997 | 8 |
| 11 | Adjuvant Therapy for Early-Stage Epithelial Ovarian Cancer | 1997 | 1 |
| 12 | 1996 | 27 | |
| 13 | 1994 | 0 | |
| 14 | 1992 | 50 | |
| 15 | 1992 | 15 | |
| 16 | 1992 | 16 | |
| 17 | 1990 | 19 | |
| 18 | 1989 | 8 | |
| 19 | 1988 | 8 | |
| 20 | 1988 | 5 |
About C. Tropé
C. Tropé is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Oncology, Cancer Research and Genetics, having authored 44 papers that have together received 1.0k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (23 papers), Endometrial and Cervical Cancer Treatments (13 papers), BRCA gene mutations in cancer (4 papers), Estrogen and related hormone effects (4 papers), Colorectal and Anal Carcinomas (3 papers), Intraperitoneal and Appendiceal Malignancies (3 papers), Cancer Treatment and Pharmacology (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). The work is most often cited by research in Reproductive Medicine (425 citations), Obstetrics and Gynecology (380 citations), Cancer Research (219 citations), Oncology (215 citations) and Surgery (263 citations). C. Tropé has collaborated with scholars based in Norway, Sweden and Belgium. Frequent co-authors include Kolbein Sundfør, Heidi Lyng, J. Kærn, E K Rofstad, Christian Marth, Einar K. Rofstad, Vera M. Abeler, Marit Scheistrøen, Ignace Vergote and Mathias Onsrud. Their work appears in journals such as Gynecologic Oncology, International Journal of Gynecological Cancer, Cancer, European Journal of Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.